Inhibitors of farnesyltransferase: A rational approach to cancer chemotherapy?

被引：72

作者：

Bell, IM ^{[1
]}

机构：

[1] Merck Res Labs, W Point, PA 19486 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 08期

关键词：

D O I：

10.1021/jm0305467

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

[No abstract available]

引用

页码：1869 / 1878

页数：10

共 75 条

[1]

Adjei AA, 2000, CANCER RES, V60, P1871

[2]

Adjei AA, 2000, CLIN CANCER RES, V6, P2318

[3]

Adjei AA, 2003, CLIN CANCER RES, V9, P2520

[4] Design and in vivo analysis of potent non-thiol inhibitors of farnesyl protein transferase [J].

Anthony, NJ ;

Gomez, RP ;

Schaber, MD ;

Mosser, SD ;

Hamilton, KA ;

O'Neil, TJ ;

Koblan, KS ;

Graham, SL ;

Hartman, GD ;

Shah, D ;

Rands, E ;

Kohl, NE ;

Gibbs, JB ;

Oliff, AI .

JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) :3356-3368

[5] Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules [J].

Ashar, HR ;

James, L ;

Gray, K ;

Carr, D ;

Black, S ;

Armstrong, L ;

Bishop, WR ;

Kirschmeier, P .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) :30451-30457

[6] The farnesyl transferase inhibitor SCH 66336 induces a G2 → M or G1 pause in sensitive human tumor cell lines [J].

Ashar, HR ;

James, L ;

Gray, K ;

Carr, D ;

McGuirk, M ;

Maxwell, E ;

Black, S ;

Armstrong, L ;

Doll, RJ ;

Taveras, AG ;

Bishop, WR ;

Kirschmeier, P .

EXPERIMENTAL CELL RESEARCH, 2001, 262 (01) :17-27

[7] 3-aminopyrrolidinone farnesyltransferase inhibitors: Design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency [J].

Bell, IM ;

Gallicchio, SN ;

Abrams, M ;

Beese, LS ;

Beshore, DC ;

Bhimnathwala, H ;

Bogusky, MJ ;

Buser, CA ;

Culberson, JC ;

Davide, J ;

Ellis-Hutchings, M ;

Fernandes, C ;

Gibbs, JB ;

Graham, SL ;

Hamilton, KA ;

Hartman, GD ;

Heimbrook, DC ;

Homnick, CF ;

Huber, HE ;

Huff, JR ;

Kassahun, K ;

Koblan, KS ;

Kohl, NE ;

Lobell, RB ;

Lynch, JJ ;

Robinson, R ;

Rodrigues, AD ;

Taylor, JS ;

Walsh, ES ;

Williams, TM ;

Zartman, CB .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (12) :2388-2409

[8]

BOS JL, 1989, CANCER RES, V49, P4682

[9]

Britten CD, 2001, CLIN CANCER RES, V7, P3894

[10] P21RAS IS MODIFIED BY A FARNESYL ISOPRENOID [J].

CASEY, PJ ;

SOLSKI, PA ;

DER, CJ ;

BUSS, JE .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8323-8327

← 1 2 3 4 5 6 7 8 →